Karyopharm Therapeutics
NASDAQ: KPTI
Healthcare
Biotechnology
Rank
#28333
Market Cap
52.71 M
Volume
56,182
Price
6.15
Change (%)
2.33%
Country or region
United States
United States
Karyopharm Therapeutics's latest marketcap:
52.71 M
As of May 13, 2025, Karyopharm Therapeutics's market capitalization has reached $52.71 M. According to our data, Karyopharm Therapeutics is the 28333th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 52.71 M |
| Revenue (ttm) | 142.13 M |
| Net Income (ttm) | -62,522,000 |
| Shares Out | 8.57 M |
| EPS (ttm) | -12.57 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 12, 2025 |
Market Cap Chart
Data Updated: May 13, 2025
Karyopharm Therapeutics's yearly market capitalization.
Karyopharm Therapeutics has seen its market value drop from $681.90 M to $52.71 M since 2013, representing a total decrease of 92.27% and an annual compound decline rate (CAGR) of 20.17%.
| Date | Market Cap | Change (%) |
|---|---|---|
| May 13, 2025 | $52.71 M | -40.26% |
| December 31, 2024 | $84.70 M | -14.53% |
| December 29, 2023 | $99.10 M | -64.08% |
| December 30, 2022 | $275.90 M | -43.21% |
| December 31, 2021 | $485.80 M | -57.36% |
| December 31, 2020 | $1.14 B | -5.35% |
| December 31, 2019 | $1.20 B | 111.62% |
| December 31, 2018 | $568.80 M | 25.59% |
| December 29, 2017 | $452.90 M | 16.82% |
| December 30, 2016 | $387.70 M | -18.12% |
| December 31, 2015 | $473.50 M | -61.32% |
| December 31, 2014 | $1.22 B | 79.5% |
| December 31, 2013 | $681.90 M |
Company Profile
Frequently Asked Questions
As of May 13, 2025, Karyopharm Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $52.71 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Karyopharm Therapeutics global market capitalization ranking is approximately 28333 as of May 13, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2008 |
| IPO Date | November 6, 2013 |
| Employees | 279 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |